Comparison of the User Experience of Four Nasal Aspirators in Infants

Not Applicable

Recruiting

• Conditions: Upper Respiratory Tract Infection

• Registration Number: NCT06816875
• Lead Sponsor: Children's Hospital of Eastern Ontario

Brief Summary

The goal of this clinical trial is to compare the caregiver's user experience, and overall impacts on an infant's cold symptoms between four nasal aspirator devices. These devices are normally used to relieve congestion in infants. when they are sick by softening and suctioning mucus from the nose.

The main questions it aims to answer are:

What is the caregiver's user experience of the NozeBot electric nasal aspirator compared to three commonly accessible nasal aspirator devices?

Are there changes in the infant's sleeping, feeding, or breathing as reported by the caregiver when using the NozeBot compared to the three other nasal aspirator devices?

Are there changes in their caregiver's habits when using the NozeBot compared to the three other nasal aspirator devices?

Researchers will compare the self-reported measures of caregiver's user experience, reported changes to their infant's symptoms, and reported changes to their own sleeping and care habits between the NozeBot electric nasal aspirator and three comparator devices: the NoseFrida SnotSucker, the hydraSense Baby Nasal Aspirator Kit, and the Braun electric nasal aspirator.

Participants will be assigned to receive one of the four devices at the start of their participation. They will be asked to use the assigned device at home according to the device instructions during two periods: (1) for 10 days while their infant is sick, and (2) for up to 3 months after.

During these periods, participants will be asked to complete online surveys at predetermined intervals to report the user experience, any changes to their infant's sleeping, feeding or breathing, and any changes to their own sleeping habits and perceived stress levels. These intervals for survey completion are: (i) after 1-2 days of use while their infant is sick, (ii) after 4-5 days of use while their infant is sick, (iii) after 7-10 days of use while their infant is sick, and then (iv) biweekly for 3 months.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2025-01-27
• Study First Submitted QC: 2025-02-06
• Status Verified: 2025-03
• Study Start: 2025-03-05
• Study First Posted: 2025-03-25
• Last Update Submitted: 2025-03-27
• Last Update Posted: 2025-04-02
• Primary Completion: 2025-07
• Study Completion: 2025-07

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Differences in the caregiver's reported net promoter score between the NozeBot and the NoseFrida, hydraSense and Braun devices	This is reported at the 7-10 days of device use to the final survey completed at the end of the third month of use per participant.	The third measure of user experience is the a rating by the caregiver on whether they would recommend the device to someone when their child is sick (also known as Net Promoter Score). This is reported on a 5-point Likert scale (1 - very unlikely to 5 - very likely) once at the 7-10 days of use while their chlid is sick, and at each bi-weekly survey over the 3 months.
Differences in the caregiver's user experience on device ease of use between the NozeBot and the NoseFrida, hydraSense and Braun devices	This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant	The first measure of user experience is the self-reported rating by the caregivers on the ease of use of the device, including device set up, use, and cleaning after use. This is reported on a 5-point Likert scale (1 - difficult to 5 - easy) at each of the survey follow ups.
Differences in the caregiver's satisfaction between the NozeBot and the NoseFrida, hydraSense and Braun devices	This is reported at the 7-10 days of device use to the final survey completed at the end of the third month of use per participant.	The second measure of user experience is the caregiver-reported satisfaction with the device, including confidence that the device is helping their infant, and that the device's power is sufficiently removing mucus. This is reported on a 5-point Likert scale (1 - very dissatisfied to 5 - very satisfied) once at the 7-10 days of use while their child is sick, and at each bi-weekly survey over the 3 months.

Secondary Outcome Measures

Name	Time	Method
Self-reported changes in the caregiver's perceived ability to care for their sick child between the NozeBot and the NoseFrida, hydraSense and Braun devices	This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant	Recorded as self-reported perceived changes to the caregivers' ability to take care of their child during the time that their child is sick since they started using the device in the study. This is reported on a 5-point Likert scale (1- much less able to 5 - a lot more capable) at each of the survey follow ups.
Self-reported changes in the caregiver's perceived stress levels while caring for a sick child between the NozeBot and the NoseFrida, hydraSense and Braun devices	This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant	Recorded as self-reported perceived changes to the caregivers' stress levels experienced while their child is sick since they started using the device in the study. This is reported on a 5-point Likert scale (1- strongly disagree to 5 - strongly agree) at each of the survey follow ups.
Caregiver-reported changes in their infant's sleeping habits between the NozeBot and the NoseFrida, hydraSense and Braun devices	This is reported at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.	Reported as caregiver-rated perceived changes in their infant's sleeping habits since they started using the device in the study on a 7-point Likert scale (1 - sleeping much worse to 4 - no changes in sleep to 7 - sleeping much better).
Self-reported changes in the caregiver's sleep habits between the NozeBot and the NoseFrida, hydraSense and Braun devices	This is reported at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.	Recorded as self-reported perceived changes to the caregivers' sleeping habits during the time that their child is sick since they started using the device in the study. This is reported on a 5-point Likert scale (1 - much less than normal to 5 - a lot more than normal) at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.
Caregiver-reported changes in their infant's feeding habits between the NozeBot and the NoseFrida, hydraSense and Braun devices	This is reported at the 1-2 days of use, 4-5 days of use, and 7-10 days of use follow up surveys.	Reported as caregiver-rated perceived changes in their infant's feeding habits since they started using the device in the study on a 7-point Likert scale (1 - much harder to feed to 4 - no changes to feeding to 7 - much easier to feed).
Caregiver-reported perceived changes in their infant's breathing between the NozeBot and the NoseFrida, hydraSense and Braun devices	This is reported at all follow ups, from the first survey completed at 1-2 days of device use to the final survey completed at the end of the third month of use per participant	Reported as caregiver-rated perceived changes in their infant's breathing since they started using the device in the study on a 4-point Likert scale (1 - no change in breathing to 4 - breathing a lot better).

Trial Locations

Locations (1)

Children's Hospital of Eastern Ontario; 🇨🇦 Ottawa, Ontario, Canada